DSP protein-altering variants in ARVC cohorts


The table below lists the 43 rare (MAF<0.0001 in ExAC) protein-altering DSP variants identified in a cohort of 352 ARVC patients. When this rare variant frequency of 0.12216 is compared with a background population rate of 0.03148, there is a statistically significant case excess of 0.09068 (p<0.0001), which suggests that approximately 32 of these variants may be pathogenic.


Variant Type:      All protein-altering variants     -     Truncating variants     -     Non-Truncating variants
Source:      OMGL



No. Variant (CDS) Variant (Protein) Variant Type Cases (352)OMGL class ExAC frequency
1. c.3764G>A p.R1255Kmissense 1VUS0.000033
2. c.1325C>T p.S442Fmissense 1VUS0.000000
3. c.7940G>A p.G2647Dmissense 1VUS0.000008
4. c.1352G>A p.R451Hmissense 1VUS0.000000
5. c.7012G>A p.G2338Rmissense 1VUS0.000000
6. c.8309A>G p.Y2770Cmissense 1VUS0.000033
7. c.3562T>C p.Y1188Hmissense 1VUS0.000067
8. c.2799G>C p.L933Fmissense 1VUS0.000075
9. c.2161G>A p.E721Kmissense 1Likely Pathogenic0.000000
10. c.943C>T p.R315Cmissense 1VUS0.000074
11. c.4868C>G p.S1623Cmissense 1VUS0.000000
12. c.1759T>A p.Y587Nmissense 1VUS0.000000
13. c.4117A>G p.T1373Amissense 1VUS0.000091
14. c.8390T>C p.I2797Tmissense 1VUS0.000032
15. c.1445G>A p.C482Ymissense 1VUS0.000000
16. c.7784C>T p.T2595Imissense 1VUS0.000008
17. c.6181C>T p.P2061Smissense 1VUS0.000000
18. c.1103T>C p.I368Tmissense 1VUS0.000074
19. c.8120T>C p.M2707Tmissense 1VUS0.000008
20. c.2609T>C p.I870Tmissense 1VUS0.000008
21. c.4996C>T p.R1666Wmissense 1VUS0.000066
22. c.944G>C p.R315Pmissense 1VUS0.000000
23. c.478C>T p.R160Xnonsense 1Pathogenic0.000000
24. c.415C>T p.Q139Xnonsense 1Pathogenic0.000000
25. c.6496C>T p.R2166Xnonsense 1Pathogenic0.000000
26. c.4477G>T p.E1493Xnonsense 1Pathogenic0.000000
27. c.1288G>T p.E430Xnonsense 2Pathogenic0.000000
28. c.3195C>G p.Y1065Xnonsense 1Likely Pathogenic0.000000
29. c.3133C>T p.R1045Xnonsense 1Pathogenic0.000000
30. c.2046C>A p.C682Xnonsense 1Likely Pathogenic0.000000
31. c.4501G>T p.E1501Xnonsense 1Pathogenic0.000000
32. c.2130+1G>C essential splice site 1Pathogenic0.000000
33. c.1755dup p.His586Thrfs*9frameshift 1Pathogenic0.000000
34. c.3329del p.Lys1110Argfs*5frameshift 1Pathogenic0.000000
35. c.1124dup p.Asn375Lysfs*9frameshift 1Pathogenic0.000000
36. c.1068dup p.Gln357Alafs*13frameshift 1Pathogenic0.000000
37. c.6118_6121del p.Ile2040Alafs*18frameshift 1Pathogenic0.000000
38. c.818dup p.Asn274Glufs*15frameshift 1Pathogenic0.000000
39. c.8077_8080del p.Lys2693Profs*3frameshift 1Likely Pathogenic0.000000
40. c.3735_3741dup p.Asp1248Lysfs*7frameshift 1Pathogenic0.000000
41. c.1188_1195dup p.Ile399Argfs*44frameshift 1Pathogenic0.000000
42. c.5659_5660del p.Lys1887Glufs*2frameshift 1Pathogenic0.000000

References

1. Roddy Walsh, Kate L. Thomson, James S. Ware, Birgit H. Funke, Jessica Woodley, Karen J. McGuire, Francesco Mazzarotto, Edward Blair, Anneke Seller, Jenny C. Taylor, Eric V. Minikel, Exome Aggregation Consortium, Daniel G. MacArthur, Martin Farrall, Stuart A. Cook and Hugh Watkins. Reassessment of Mendelian gene pathogenicity using 7,855 cardiomyopathy cases and 60,706 reference samples. Genet Med. 2016 doi:10.1038/gim.2016.90.